Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oral capsule faecal microbiota transplantation
- Development stage
- Unknown
- Lead developer
- Tan Tock Seng Hospital
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Oral capsule faecal microbiota transplantation (FMT) is a microbiome-based therapeutic intervention developed by Tan Tock Seng Hospital. It involves the oral administration of capsules containing processed healthy donor stool from a stool bank. The primary mechanism of action is the restoration of a diverse and functional intestinal microbiota, which provides colonization resistance against multidrug-resistant organisms. Specifically, it is intended to decolonize carbapenemase-producing Enterobacteriaceae (CPE) from the gastrointestinal tract of colonized patients, thereby reducing the risk of subsequent clinical infection and transmission. It is currently being evaluated in a Phase 2/3 clinical trial for intestinal CPE decolonization.
- Other names
- FMT capsulesFaecal microbiota transplantation capsules
Beyond the preview
Go deeper on Oral capsule faecal microbiota transplantation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oral capsule faecal microbiota transplantation.